BPC-157
REPORTED STUDY DOSAGE STATUSNo validated human dose
TB-500
REPORTED STUDY DOSAGE STATUSNo validated human dose
GHK-Cu
REPORTED STUDY DOSAGE STATUSNo validated systemic human dose
MOTS-c
REPORTED STUDY DOSAGE STATUSNo established human dose
Retatrutide
REPORTED STUDY DOSAGE STATUS1, 4, 8 & 12 mg in a supervised phase 2 trial
Tirzepatide
REPORTED STUDY DOSAGE STATUS5, 10 & 15 mg in a regulated phase 3 trial
CJC + Ipamorelin
REPORTED STUDY DOSAGE STATUSNo validated blend dose
NAD+
REPORTED STUDY DOSAGE STATUSNo standard for this research format
KLOW
REPORTED STUDY DOSAGE STATUSNo validated blend protocol
Explore the interactive research reference for category filters, literature context, detailed limitations and full research profiles. Cambrian BioLabs provides laboratory research products only, not human or veterinary dosing advice. Research reviewed October 2026.